Company Filing History:
Years Active: 2014
Title: Celebrating the Innovations of Jiehao Chen in Glycosylated Proteins
Introduction
Jiehao Chen is an innovative inventor based in Westfield, IN, who has made significant strides in the field of biochemistry. With a focus on the development of glycosylated proteins, his work contributes to advancements in therapeutic applications, particularly in the realm of cancer treatment.
Latest Patents
Jiehao Chen holds one patent titled "Compositions comprising homogeneously glycosylated erythropoietin." This invention encompasses isolated homogeneous polyfunctionalized proteins, such as erythropoietin, along with isolated glycopeptides. The patent articulates methods for preparing these polyfunctionalized peptides and proteins through cysteine-free native chemical ligation. It provides distinct embodiments for both homogeneous polyfunctionalized proteins and glycopeptides, enhancing the existing knowledge in protein chemistry.
Career Highlights
Jiehao Chen is associated with the prestigious Sloan Kettering Institute for Cancer Research, where he applies his expertise in biochemistry to advance research in cancer therapies. His commitment to innovation and research continues to play a vital role in the scientific community.
Collaborations
Collaborating with esteemed colleagues such as Samuel J. Danishefsky and J. David Warren, Jiehao Chen leverages their collective knowledge and expertise, paving the way for groundbreaking research and development in the field of glycosylated proteins.
Conclusion
Jiehao Chen’s contributions to the development of glycosylated proteins demonstrate his expertise and commitment to research in biochemistry. His patent on homogeneously glycosylated erythropoietin not only showcases his innovative capabilities but also holds potential for significant advancements in therapeutic applications, particularly within cancer research.